BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY SECTOR
Javier Terriente - 23 June 2026
Zebrafish subchronic toxicity testing meets REACH requirements. Early-life stage fish studies deliver growth, reproduction and organ-level data — with lower costs and animal use.
Javier Terriente - 09 June 2026
Detect ototoxicity earlier with zebrafish lateral line assays. Screen aminoglycoside and cisplatin hair cell damage before rodent ABR studies at scale.
Javier Terriente - 27 May 2026
Improve translatability in preclinical research using predictive in vivo models to reduce clinical failure and strengthen early drug development decisions.
Javier Terriente - 13 May 2026
High-throughput screening in early drug discovery: when to integrate in vivo models to improve candidate selection and reduce preclinical risk.
Javier Terriente - 23 April 2026
Each year, tens of thousands of fish and other aquatic vertebrates are used in regulatory ecotoxicity studies across Europe alone. As scientific advances and regulatory pressure converge to reduce animal use in chemical safety testing, the industry is undergoing a directional shift to progressively expand the use of new approach methodologies (NAMs). The Need for […]
Javier Terriente - 14 April 2026
Zebrafish immunology models enable in vivo analysis of immune responses and inflammation, advancing drug discovery with scalable assays and translational insights.
Javier Terriente - 27 March 2026
Scientific analysis of animal testing pros and cons in preclinical drug development, including alternatives, 3Rs strategy, and translational impact.
Javier Terriente - 18 March 2026
How can genetic testing results be functionally validated in vivo to confirm variant pathogenicity in precision medicine?
Javier Terriente - 24 February 2026
Zebrafish models enable high-throughput screening of diabetic retinopathy, combining advanced phenotypic readouts and drug discovery efficiency.
Javier Terriente - 12 February 2026
Zebrafish models enable cost-effective, high-throughput screening of metabolic diseases for accelerated preclinical drug discovery.
Miriam Martínez - 29 January 2026
Zebrafish-based bioimaging enables real-time in vivo visualization of organ-level drug effects using automated, high-throughput platforms.
Miriam Martínez - 16 January 2026
Behavioral phenotyping in zebrafish assesses CNS drug effects through high-throughput screening and predictive preclinical insights
Miriam Martínez - 17 December 2025
How zebrafish models are advancing microbiome studies, including germ-free models and gut development insights for translational research.
Miriam Martínez - 11 December 2025
How zebrafish models support retinal repair studies and preclinical research into stem-cell-based eye therapies.
Miriam Martínez - 24 November 2025
How zebrafish neurological models bridge in vitro and mammalian systems to enable high-throughput, functional disease modeling for early-stage drug discovery.
Miriam Martínez - 10 November 2025
How to validate AI-driven drug discovery predictions using zebrafish models with in vivo precision, speed, and biological insight.
Miriam Martínez - 29 October 2025
Why zebrafish male vs female differences impact in drug discovery. Improve preclinical efficacy and safety with sex-aware zebrafish models.
Miriam Martínez - 15 October 2025
Zebrafish efficacy assays unlock therapeutic potential in drug discovery. Explore applications in cancer research, neurology, and regenerative medicine.
Miriam Martínez - 25 September 2025
Zebrafish neurotoxicity screening helps predict drug safety, identifying neurotoxicity symptoms, risk factors, and effects with precise in vivo models.
Miriam - 15 September 2025
How zebrafish enhance cardiotoxicity screening, improve early detection of cardiac risk, and support safer drug development in preclinical studies.
Miriam Martínez - 21 August 2025
Good Laboratory Practices (GLP) ensure reliable preclinical research, meet FDA standards, and strengthen data integrity in drug development.
Miriam Martínez - 12 August 2025
Clinical trial phases and FDA approval in drug development. Understand timelines, phase differences, and key regulatory milestones in one clear guide.
Miriam Martinez - 22 July 2025
Developmental neurotoxicity insights using zebrafish behavioral assays: discover how this in vivo model advances preclinical drug discovery decisions.
Miriam Martínez - 11 July 2025
Zebrafish cancer models enable in vivo drug screening and tumor tracking, helping develop targeted anticancer therapies in oncology drug development.
Miriam Martínez - 26 June 2025
Developmental Toxicity of PROTACs: Explore in vivo screening strategies, safety concerns, and regulatory insights to support safer drug development.
Miriam Martínez - 23 June 2025
Zebrafish toxicity screening helps accelerate drug discovery with early safety insights. Explore 3 fast, cost-effective strategies to de-risk compounds.
Miriam Martínez - 20 June 2025
Exploring how zebrafish models accelerate neurological drug discovery through high-throughput screening and in vivo insights
Miriam Martínez - 17 June 2025
Discover how zebrafish models of human disease are revolutionizing research in neurology, oncology, infections, and rare disorders with real-world breakthroughs.
Miriam Martínez - 13 June 2025
Discover how zebrafish are advancing modeling human diseases in neurology, cardiology, oncology, and ophthalmology.
Miriam Martinez - 11 June 2025
How zebrafish enhance lead optimization, ADME prediction, and drug discovery efficiency in early-stage development.
Miriam Martínez - 06 June 2025
Learn how zebrafish revolutionize pharmaceutical toxicology by enabling high-throughput environmental and human risk assessments.
Miriam Martínez - 03 June 2025
Learn about environmental risk assessment (ERA) for medicinal products, including PBT/vPvB evaluations and the role of zebrafish in them.
Miriam Martínez - 29 May 2025
Developmental toxicity screening using zebrafish offers a predictive, ethical, and cost-effective in vivo model aligned with ICH S5 (R3) standards.
Miriam Martínez - 22 May 2025
Explore zebrafish disease models built with CRISPR, Tol2, and morpholinos for precise genetic research.
Miriam Martínez - 15 May 2025
Reproductive toxicity testing with zebrafish provides fast, predictive insights for early-stage drug development aligned with ICH guidelines.
Miriam Martínez - 07 May 2025
Explore non-clinical safety assessments for new drugs, from ICH guidelines to zebrafish models in preclinical toxicology.
Miriam Martínez - 05 May 2025
Discover why zebrafish are becoming key human disease models for studying genetics, disease mechanisms, and drug discovery with speed and precision.
Miriam Martínez Navarro - 30 April 2025
How zebrafish in vivo models enhance target validation in drug discovery and support early-stage drug development.
Miriam Martínez - 25 April 2025
Discover the strengths and limitations of zebrafish, mice, and other model organisms, comparing human gene homology, brood size and life cycle.
Miriam Martínez - 22 April 2025
Discover how zebrafish preclinical research accelerates drug discovery. Explore 3 key use cases for efficacy, toxicity, and disease modeling.
Miriam Martínez Navarro - 15 April 2025
Zebrafish models enhance hit-to-lead optimization, accelerating early drug development with high-throughput screening.
Miriam Martínez Navarro - 09 April 2025
Learn about zebrafish development, from embryo to larvae. Discover the zebrafish developmental stages and why they’re ideal for biomedical research.
Miriam Martínez - 31 March 2025
Optimize drug discovery pipelines with zebrafish high-throughput screening. Discover automation, robotics & phenotypic screening solutions.
Miriam Martínez - 26 March 2025
The Drug Discovery and Development Process: Context and Functions
Miriam Martínez - 21 March 2025
Exploring how zebrafish screening transformed cardiomyopathy drug development, reducing costs and accelerating timelines
Miriam Martínez - 17 March 2025
Accelerating Drug Development with Zebrafish Models
Miriam Martínez - 13 March 2025
Exploring the Benefits of Zebrafish Model in Modern Research
Miriam Martínez - 04 March 2025
Advancing Drug Discovery with Zebrafish High-Content Screening
Miriam Martínez - 26 February 2025
Leveraging Zebrafish for Reduction, Refinement, and Replacement in Preclinical Studies
Miriam Martínez - 20 February 2025
Identifying Successfully Injected Embryos With Fluorescence
Miriam Martínez - 17 February 2025
How To Do A Microinjection of Zebrafish Embryos?
Miriam Martínez - 12 February 2025
Proven Techniques for Successful Zebrafish Reproduction and Embryo Collection
Miriam Martínez - 10 February 2025
Understanding Shared Genes and Their Impact on Human Medicine
Miriam Martinez - 05 February 2025
What Does Zebrafish Eat? Balancing Nutrition and Convenience with Live and Dry Food
Miriam Martínez Navarro - 03 February 2025
Essential Zebrafish Husbandry Practices for Effective Tank Cleaning and Disinfection
Miriam Martínez Navarro - 30 January 2025
Best Practices for Zebrafish Husbandry: Monitoring Health and Maintaining Rack Systems
Miriam Martínez Navarro - 27 January 2025
Best Practices for Long-Term Zebrafish Care and Husbandry
Miriam Martínez Navarro - 23 January 2025
A Step-by-Step Guide to Establishing a Thriving Zebrafish Colony
Miriam Martínez Navarro - 20 January 2025
Essential Water Quality Tips for Healthy and Thriving Zebrafish
Miriam Martínez Navarro - 16 January 2025
Temperature, pH, Conductivity and Density Guidelines for Zebrafish Husbandry
Miriam Martínez Navarro - 13 January 2025
Understanding Zebrafish Biology and Behavior in Research
Miriam Martínez Navarro - 08 January 2025
From Ornamental Fish to a Cornerstone of Scientific Discovery
Miriam Martínez - 28 October 2024
Discover how zebrafish accelerate early-stage screening, enhance predictive insights, and reduce costs in drug development
Miriam Martínez - 21 October 2024
Is the Traditional Drug Discovery Process Holding Back Your Pipeline?
Miriam Martínez Navarro - 20 September 2024
The Impact of AI on Pipelines, Productivity, and Clinical Success
Sylvia Dyballa - 06 September 2024
How Does ZeClinics Take Advantage of Data Science?
Elena Abad - 02 August 2024
Leveraging Relationships in Knowledge Graphs to Enhance Drug Discovery and Target Identification
Miriam Martínez - 16 July 2024
Key Mistakes to Avoid for Successful Zebrafish Genetic Modeling
Miriam Martínez - 04 July 2024
Evaluating Methods for Precision and Efficiency in Genetic Engineering
Miriam Martínez - 17 June 2024
Transgenic Animals Meaning + Application Examples
Miriam Martínez - 28 May 2024
Two Applications of CRISPR/Cas9 Gene Knockout
Ana G. Duran - 30 April 2024
Readily assess visual function in a live organism
Miriam Martínez - 11 April 2024
Understanding DNA Repair Pathways
Miriam Martínez - 19 March 2024
Harness the potential of our new Zebrafish-Based Platform for High-Throughput Gene Target Validation and Drug Screening in F0
Flavia de Santis - 05 March 2024
The use of target gene-editing in preclinical research
Miriam Martínez - 13 February 2024
The most precise CRISPR to date turns the genetic scissors into a Swiss army knife
Valentina Schiavone - 26 April 2023
The United States approves technological alternatives to reduce animal testing
Miriam Martínez - 28 March 2023
What is CRISPR technology and how can change our lives?
Miriam Martínez - 15 February 2023
Gene editing enables scientists to alter the sequence of genes by adding, replacing, or removing certain DNA segments.
Miriam Martínez - 17 January 2023
How does genetic information pass down through generations and what errors can occur?
Miriam Martínez - 20 December 2022
The correspondence between two biological languages
Miriam Martínez - 05 December 2022
What is the relationship between DNA, RNA and proteins?
Carles Cornet - 16 November 2022
Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.
Miriam Martínez - 13 October 2022
Zebrafish contribution to drug development reaching clinical stages
Javier Terriente - 15 September 2022
AI can address many challenges and limitations in traditional R&D and offer value in drug discovery in multiple ways.
Miriam Martínez - 27 July 2022
Zebrafish for regulatory purposes in ecotoxicology and safety pharmacology
Miriam Martínez - 30 June 2022
New trends and updated availability for zebrafish studies in EU and US
Carles Cornet - 11 May 2022
Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs
Miriam Martínez - 16 March 2022
How to choose which type of experiment is best-suited for my research?
Javier Terriente - 19 January 2022
Use of biomarkers in endocrine disruption compounds screening and testing with zebrafish
Vincenzo Di Donato - 24 November 2021
Leveraging zebrafish to study Age-related Macular Degeneration
Christian Cortés - 20 September 2021
The emerging use of zebrafish to model metabolic diseases
Miriam Martínez - 21 July 2021
Are zebrafish suitable for human drug discovery?
Nicolás Palanca - 28 June 2021
The regulatory status of zebrafish as an alternative preclinical model.
Sylvia Dyballa - 12 May 2021
In ZeClinics we bet on emerging technologies to scale our solutions.
Davide Rubbini - 20 April 2021
Zebrafish represents a key tool to boost drug discovery by enabling phenotypic screening approach in pharmacological-based disease models.
Sergio Jarque - 10 March 2021
From challenge to knowledge: the outstanding performance of zebrafish in predicting toxicity.
Flavia de Santis - 10 February 2021
ZeClinics can do it by using different genome editing approaches.
Vincenzo Di Donato - 13 January 2021
ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.
Javier Terriente - 02 December 2020
We knew the model was brilliant for academic research. Would it be as good for modeling human disease and discovering new drugs in an industrial setting?